A Clinical Trial to Evaluate Safety, Tolerability &

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02587442` - A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers	Phase 1
Completed	`NCT00504335` - Safety and Pharmacokinetic Study of BIO 300 Capsules	Phase 1
Completed	`NCT04650555` - BIO 300 Oral Powder Safety and Pharmacokinetics	Phase 1
Active, not recruiting	`NCT00903929` - Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation	Phase 1

See also

Status

Clinical Trial

Phase

Recruiting

NCT02587442 - A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers

Phase 1

Completed

NCT00504335 - Safety and Pharmacokinetic Study of BIO 300 Capsules

Phase 1

Completed

NCT04650555 - BIO 300 Oral Powder Safety and Pharmacokinetics

Phase 1

Active, not recruiting

NCT00903929 - Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03585803
Study type	Interventional
Source	Intron Biotechnology, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	June 11, 2018
Completion date	November 28, 2019

A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms